Based in purpose-built facilities in the Northwest of England, Quay Pharmaceuticals Limited provides a comprehensive outsourcing service for the development and testing of pharmaceutical products. Quay Pharma has particular expertise in oral dosage form design and development, in particular novel drugs that exhibit poor solubility and bio-availability.
  • Pre-formulation
  • Formulation development
  • Analytical method development and contract analysis
    (including stability testing to ICH guidelines)
  • Manufacture of clinical trial supplies

The company is headed by Professor Mike Rubinstein, who has over 30 years experience in pharmaceutical dosage form design, development and manufacturing.